PhD neuroscientist building precision neurotechnology for psychedelic-assisted therapy. Founder @ Psio NeuroRecovery | TEDx Speaker
Joined December 2020
- Tweets 612
- Following 1,447
- Followers 2,863
- Likes 3,893
137 Photos and videos
Pinned Tweet
21 Nov 2025
My TEDx talk is live! I share my path from TBI to heroin addiction to neuroscientist, along with simple strategies for resilience and top-down control. I’d truly appreciate you sharing it.
youtube.com/watch?v=08LgirAD…
1
4
14
2,332
Devin Effinger, PhD retweeted
Our first Deep Dive of 2026 covers a recent Perspective calling for recognizing and removing the barriers faced by researchers with lived experience of mental illness or SUDs who work in our field.
By @UmaRChatterjee, @SchumerMaya, @devin_effinger & colleagues.
youtu.be/y5fymczeNFc
1
9
10
1,879
Devin Effinger, PhD retweeted
27 Dec 2025
Postdoctoral fellowship available in structure guided drug discovery in @RothLabUNC
Please RT
2
46
49
8,681
Devin Effinger, PhD retweeted
Researchers with lived experience of mental illness or SUDs bring vital expertise & insight to our field, yet remain underrepresented and face barriers to participation and leadership.
This Perspective from @UmaRChatterjee, @SchumerMaya, @devin_effinger, @viscidula, @noelvest, Michael Cahill, @BStaglin, @EricJNestler calls for breaking these barriers and proposes actionable strategies to build more inclusive environments by reforming admissions, mentorship, and leadership pathways.
nature.com/articles/s44277-0…
15
25
3,849
Devin Effinger, PhD retweeted
21 Oct 2025
🚨 Please RT!
We’re recruiting a motivated postdoc to dissect the neurocircuits of affective pain.
Expertise in behavioral models of pain/SUDs, stereotaxy, microscopy, opto/chemogenetics, or fiber photometry encouraged.
Apply 👉 recruit.apo.ucla.edu/JPF1064…
#Neuroscience #Postdoc
1
34
43
6,693
2 Oct 2025
If anyone is looking (or know of someone) for a roommate and has a spot at the Atlantis for @ACNPorg , please let me know!
5
4
1,387
Devin Effinger, PhD retweeted
1 Oct 2025
Devin Effinger @devin_effinger and @MelissaHerman4 argue that, though many human psychedelic clinical trials are underway, preclinical studies remain our best bet to answer fundamental questions about the neurobiology of psychedelics.
thetransmitter.org/psychedel…
11
25
1,689
29 Sep 2025
What an honor! Humbled and grateful. It was a beautiful disaster and a perfect metaphor for my recovery ending with a standing ovation. Thank you so much to the organizers and stay tuned for the link! @TEDxBoulder
1
5
17
993
23 Aug 2025
🚨 New paper 🚨
For years, there has been concern that psychedelics might pose cardiovascular risks due to their agonist activity at the 5-HT2B receptor — the same target linked to drug-induced heart disease.
pubs.acs.org/doi/full/10.102…
4
12
46
4,177
23 Aug 2025
Pharmacokinetic modeling gave us a potential explanation:
👉 Fenfluramine is still present in blood at 24h, leading to sustained and chronic 5-HT2B activation.
👉 Low doses of LSD and psilocin are both off the receptor within 8-10h.
2
2
305
23 Aug 2025
Takeaway: In mice, 8 weeks of low-dose LSD produced no evidence of heart damage.
But human studies are still essential — especially in people with cardiovascular risk factors.
2
279
Devin Effinger, PhD retweeted
13 Aug 2025
@ACNPorg brought @UmaRChatterjee
@devin_effinger & me together last year: After finding each other on X-as we are all public/open about our lived experience -we met and discussed the ideas for this Study Group! Looking forward to doing this work together@ #ACNP2026🧠❤️💥‼️
12 Aug 2025
THRILLED to share @ACNPorg news x2!
1) Our study group—“Centering Lived Experience in Psychiatric Neuroscience Research: Challenges, Opportunities, & Calls to Action” @EricJNestler @BStaglin @SchumerMaya @devin_effinger @viscidula @noelvest @MichaelECahill1=ACCEPTED! 🤩#ACNP2026
1
11
22
2,692
Devin Effinger, PhD retweeted
12 Aug 2025
THRILLED to share @ACNPorg news x2!
1) Our study group—“Centering Lived Experience in Psychiatric Neuroscience Research: Challenges, Opportunities, & Calls to Action” @EricJNestler @BStaglin @SchumerMaya @devin_effinger @viscidula @noelvest @MichaelECahill1=ACCEPTED! 🤩#ACNP2026
2
7
24
5,596
Devin Effinger, PhD retweeted
6 Aug 2025
My recent email to @NIHDirector_Jay
@RobertKennedyJr
Please RT!
1
22
44
7,605
31 Jul 2025
It’s wild how much change is possible in this life. From relearning to talk post-TBI, to full blown heroin addiction, to a life beyond anything I could have imagined. Im very fortunate to not only be alive, but to have been selected to speak at 2025 TEDxBoulder!
5
9
58
3,195
Devin Effinger, PhD retweeted
28 Jun 2025
🚨 New preprint alert!
Intranasal esketamine helps with treatment-resistant depression—but do sex differences shape who responds best, and how?
We analyzed 5 RCTs and found striking sex-specific symptom patterns.
👉 medrxiv.org/content/10.1101/…
#Depression #Esketamine
2
6
12
1,261
18 Jul 2025
The inaugural #GRCPsychedelics was a success! I am honored to have been one of a few chosen to receive a travel award and be able to share the stage with the leaders in the field. Very grateful to the organizers. 🙏 @kwanalexc @VVyazovskiy @MelissaHerman4 @ViditaVaidya
5
25
1,288
Devin Effinger, PhD retweeted
17 Jul 2025
Save the date for Psychedelics GRC ***2029***!!
17 Jul 2025
We worked so well as a team for the #GRCPsychedelics @VVyazovskiy @MelissaHerman4 @ViditaVaidya
and congrats to @TheBorisLab and @MikaelPalner, who will be the future vice-chairs!
3
10
58
3,983
Devin Effinger, PhD retweeted
21 May 2025
I had deactivated my account out of a sense of mental preservation, and was planning to log back in every 29 days to preserve my history and connections, but I apparently failed at that task. I'm now slowly rebuilding my twitter network.
1
2
13
904